Home Newsletters Human Immunology News Proximity of Immune and Tumor Cells Underlies Response to BRAF/MEK-Targeted Therapies in...

Proximity of Immune and Tumor Cells Underlies Response to BRAF/MEK-Targeted Therapies in Metastatic Melanoma Patients

0
In a TCGA-melanoma dataset, tumor cellularity exhibited additive prognostic value in the immune score signature to predict overall survival in patients with early-stage melanoma.
[npj Precision Oncology]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version